For the last decade the serological heterogeneity of strains of Ureaplasma urealyticum isolated from humans has been represented by eight serotypes. We have identified two additional serotypes, strains Vancouver and Western. Using a modified metabolic inhibition test and a colony indirect epifluorescence method, we tested antisera to the above 10 types against the 11 members of the independent Lin-Kass classification. Four of the latter, K2, U24, U26, and U38, showed unique specificities; these were confirmed by reciprocal testing with antisera prepared against the respective strains. With the addition of these strains, the serotyping scheme now has 14 members. Since this expanded classification allows greater discrimination between strains, it will allow also for their future characterization. It provides, in addition, a potentially more effective epidemiological tool.
As one of the etiological agents of nongonococcal urethritis (4, 21) , Ureaplasma urealyticum is an established pathogen of the human genital tract. However, the observation that many individuals harboring this organism are asymptomatic makes the relationship between U. urealyticum and nongonococcal urethritis more complex. Subspeciation of isolates of U. urealyticum may allow differentiation between virulent and avirulent strains.
Isolates of U. urealyticum from the human genital tract have exhibited antigenic heterogeneity. By using Shepard's progenitor of the type strain (17) , seven serotypically distinct strains identified by Ford (5) , and strain 58 (1), Black and co-workers used a variety of serological tests to establish a typing scheme with eight specificities (1) (2) (3) that has been acknowledged by an international group of mycoplasmologists (19) . In 1979 we reported a modification of a metabolic inhibition test (MIT), originally designed by Purcell et al. (13) , and its application in characterizing antisera that we had prepared in rabbits to the eight standard serotypes and to a ninth serotype, strain Vancouver (16) . Subsequently, we further extended Black's classification by the identification of a tenth serotype, strain Westem. Lin, Kass, and co-workers used a complement-dependent mycoplasmacidal assay (that gives titers similar to those obtained by the MIT [6] ) to develop a separate, 11-member serotyping scheme for U. urealyticum (10) . We report here our attempt to correlate the two independent schemes, using the modified MIT (16) and colony epifluorescence (CEF) tests (20) .
(A preliminary report of this work was presented [Abstr. Annu. Meet. Am. Soc. Microbiol. 1980, G5, p. 77.]) MATERIALS AND METHODS Organisms. The sources of the strains of U. urealyticum used in this study are listed in Table 1 . These were the standard strains used in our earlier work (16) , with the three exceptions noted below. First, a new vial of a lyophilized culture of strain T23 was obtained from D. K. Ford as the standard for serotype 2, and antiserum was prepared to it. The antigen we initially designated as serotype 2 apparently arose by selection of a minor component of the strain 23 culture; its emergence in our second passage to dominance by our third passage was followed by the CEF test. This selected strain was unique and has been redesignated as strain Western, serotype 10. Secondly, the serotype standard 8 of our earlier work, T960, was replaced with an 8-times cloned version, T960(CX8), the type species. Antiserum to the latter gave rise to fewer cross-reactions than that to the earlier T960. Thirdly, strain 354(NIH) formed more distinct and characteristic colonies than its prototype, strain 354 (Table 1) , and was used for the serotype standard in the CEF tests. Strains 354 and 354(NIH) gave comparable titers in the MIT with the antisera to the other standard strains.
After the viability of each standard culture was ascertained, the culture was transferred twice in bromothymol blue broth (15) . When the second transfer reached late logarithmic phase growth, sterile glycerol (about 10o [vol/vol]) was added, and the culture was stored in small volumes at -70°C. These stock cultures were used to prepare inocula for the tests and for (14) . The sonicated culture was then allowed to pass by gravity through a sterile, 0.45-,um membrane filter. One milliliter of this suspension was then introduced into 9 ml of broth, and 10-fold dilutions were continued up to 104. The contents of each tube were then divided into nine 1-ml volumes in sterile tubes, and these were incubated. When a tube turned from yellow to green (indicative of growth), it was removed from the incubator and, after the addition of about 10% (vol/vol) sterile glycerol, it was stored at -70°C. The last tube to change color in the highest dilution showing growth was the cloned culture; it was used to repeat the procedure, which was performed three times on each strain. Antisera. Each strain was adapted to grow in bromothymol blue broth, in which rabbit serum was substituted for the usual 10% (vol/vol) horse serum supplement. Large batch cultures were grown in this rabbit serum-enriched broth to the late logarithmic phase and then were collected by centrifugation. The preparation of antigen and the immunization schedule used have been described (16) . By the MIT, preimmunization sera diluted 1:80 (the highest concentration tested) demonstrated no inhibitory effect against homologous strains. None of the antisera was absorbed. All were filter sterilized and stored at 4°C. Anti-rabbit immunoglobulin G was prepared in goats, and the crude immune globulin of this antiserum was then conjugated with fluorescein isothiocyanate as previously described (20) .
Assay methods. The MIT identifies serum titers that inhibit the metabolism of urea by U. urealyticum. With inhibition of urealysis, there is insufficient change in the pH of the broth medium to alter the color of the bromothymol blue indicator. The modified MIT (16) provided stable endpoints. The CEF test is an indirect immunofluorescence method carried out on unfixed colonies on agar. The modified CEF test was both performed and examined in microtiter plates (20) . Both methods have been shown to be specific for serotyping strains of U. urealyticum (e.g., 1, 5, 11, 16, 20) . Table 2 contains the MIT titers for the 10 strains of U. urealyticum which compose our set of standards; homologous reactions are italicized. With the exception of the cross-reaction between types 2 and 5, these reagents exhibited a high degree of specificity. The same set of antisera was used for MITs with the 11 strains of the Lin-Kass (L-K) scheme. The relationship of these strains to the standards is indicated in the extreme right-hand column of Table 3 . Six of the L-K strains were typed by antisera to five of the standard types. This included strain T960(CH), which reacted with both anti-2 and anti-S. Of the other five L-K strains, three had no demonstrable relationship to the 10 standard types. The two remaining strains showed anomalies. Strain K393 reacted with anti-3, anti-4, and anti-6. Although strain U26 was related to serotype 1, unlike that strain (Table 2) , it cross-reacted with anti-3.
RESULTS
Antisera were prepared to the five strains of the L-K scheme that were not clearly typable with the 10 standard antisera. For strains K2, U24, and U38, the MIT titers obtained with the homologous antiserum were at least 16 times those with the other sera (Table 4) . Anti-K393 exhibited unusual behaviour: a very high titer with standard 3, strengthening a relationship indicated by the MIT titers (Table 3) , but no significant titer with standards 4 or 6 or even with the (supposedly) homologous strain. Anti-U26 showed a significant titer with the homologous U26. However, although U26 was inhibited by anti-1 ( 160  <80  <80  80  <80  80  80  2  80  163,840  80  <80  <80  <80  80  80  160  <80   3  320  160 10,240  <80  <80  <80  80  80  80  160  4  <80  320  160 163,840  <80  <80  80  160  320  160  5  <80  40,960  80  320 40,960  <80  160  80  160  80  6  160  320  80  <80  <80 To substantiate the MIT data, we performed With the CEF test, anti-U24 and anti-U38 also CEF tests with antisera to our 10 standard showed two-way crosses that were not detected strains and to the 4 unique strains of the L-K by the MIT determinations (Table 4) . Other system against all types in both classifications. cross-reactions not seen in the MIT but identiThe six L-K antigens that were typable by the fied by the CEF method were anti-K2 with MIT gave the same results as the appropriate standards 4 and 8, anti U-38 with standard 10, standard strains when they were examined by and anti-U26 with standard 1. Thus, although the CEF test (results not shown). This left a the positive reactions obtained with CEF supbattery of 15 types. Because anti-K393 had ported the MIT findings, they also revealed reacted strongly only with itself and with stan-additional cross-reactions. Numerous other dard antigen 3 in the CEF test, we considered it cross-reactions were observed with the CEF closely related to type 3 and, therefore, eliminat-test, but for these the degree offluorescence was ed it from the expanded scheme. The CEF of significantly lower intensity than that demonreactions obtained in reciprocal testing of the strated by any of the antigens with homologous remaining 14 serotypes and antisera to them are antiserum. The significance of these weak reacpresented in Table 5 . As with the MIT, anti-1 tions needs to be elucidated. reacted strongly with antigen 1 ( Table 2) and Each of the four L-K strains that we consid-U26 (Table 3) . With the CEF test, anti-2 reacted ered unique was cloned three times and then with antigens 2 and 5 in a two-way cross, i.e., lyophilized. These preparations were then reanti-5 also reacted strongly with antigens 2 and constituted and examined by the CEF test; their 5. Only a one-way cross was apparent in the specificities were unchanged. We have designatmodified MIT (Table 2) . ed these strains (K2, U24, U38, and U26) as (Tables 2 and 5 ) have been detected in all studies in which the reagents have been compared (Table 6 ). The degree of cross-reactivity varies for a single method (MIT, growth inhibition, and CEF) and even within a given laboratory (e.g., [1, 2] ). In addition, antiserum prepared in one laboratory (18) has given different cross-reactions in other laboratories (11, 14) , although the test methods differed. It was the absence of any cross-reactions between our presumed standards 2 and 5 that alerted us to the presence of strain Western in a culture we believed was strain T23 (Table 1 and text) . Although serotypes 12 and 13 (U24 and U38) cross-reacted in the CEF test (Table 5) , they reacted differently in the MIT (Table 4) . Furthermore, wild-type isolates exist that have one or the other, but not both, specificities.
In 1973, Lin and Kass reported antigenic heterogeneity in cultures of the type strain T960. With their mycoplasmacidal test, antiserum to the cloned antigen T960(CH) did not kill T960(CX8) (8) . We found that T960(CH) had antigenicity in common with both standards 2 and 5 (Table 3) . Furthermore, two cultures of T960 sent to our laboratory have shown evidence of contamination. With the CEF tests a majority of the colonies stained with anti-8, but a minority did not. In subsequent tests a minority of colonies in these cultures reacted with anti-2 or with anti-5. This minor component could have been selected for during transfers of T960(CH), perhaps as a response to a change in growth conditions. This explanation may also apply to strain K393. Its adaption to growth in broth supplemented with rabbit serum before antigen preparation may have selected organisms with serotype 3 determinants over those with the type 4 and 6 specificities. Populations of U. urealyticum of more than one serotype have been found in the human genital tract (7, 11) . At present, subspecies of U. urealyticum are identifiable only by serological methods, and the difficulty of characterizing cultures or ascertaining the purity of a given strain should not be underestimated. We obtained an uneven response with the U26 reagents. The two-way cross-reaction seen with the CEF test (Table 5) was not apparent with the MIT (Table 3) . Both this and the other unusual reactions noted above are intriguing and may be without explanation until monospecific reagents to single antigenic determinants are available. In the meantime, the need for well-characterized reagents is obvious.
With the modified MIT and the CEF test we identified 8 of the 11 L-K strains as having specificities in common with 5 members of Black's scheme, with U26 demonstrating a relationship to both standards 1 and 3. None of the L-K strains was related to serotypes 9 or 10. The remaining three L-K strains (K2, U24, and U38) had different determinants (Tables 4 and 5) . Recently, Lin and Kass reported the results of a comparative study of the 8 established serotypes and the 11 L-K strains (9) . They found that their strains U9 and U30 belonged to the same serogroup as type 3. Earlier, they had reported that strain U30 was identical to the Boston T strain (10) . The Boston T strain has been identified by the growth inhibition test and also by our modified MIT as being closely related to type 3 (18 and J. A. Robertson and G. W. Stemke, unpublished data). Lin and Kass considered six of their strains to be unique. Our conclusions differ in regard to strains U19, Kit, and K393. We stress, however, that this does not necessarily contradict the distinct nature of the L-K strains. The two laboratories obtained seven of the initial eight standard strains from different sources; we used rabbits instead of guinea pigs for antisera production and with dissimilarly prepared immunogens; finally, different assay methods were employed. Agreement is generally good, when these variables are considered. 
